miRNA and leptin signaling in metabolic diseases and at extreme environments
Pharmacology Research & Perspectives · 2024-08 · 12 (4)
DOI: 10.1002/prp2.1248 ↗At a glance
Übersichtsarbeit in Pharmacology Research & Perspectives, published online on 2024-07-17. Written by Samrita Mondal and 3 co-authors. Institution: Defence Institute of Physiology and Allied Sciences, Delhi, India. Major MEDLINE topics: Leptin, Metabolic Diseases, MicroRNAs, Signal Transduction. Cited 18 times so far (Crossref); 182 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
The burden of growing concern about the dysregulation of metabolic processes arises due to complex interplay between environment and nutrition that has great impact on genetics and epigenetics of an individual. Thereby, any abnormality at the level of food intake regulating hormones may contribute to the development of metabolic diseases in any age group due to malnutrition, overweight, changing lifestyle, and exposure to extreme environments such as heat stress (HS), cold stress, or high altitude (HA). Hormones such as leptin, adiponectin, ghrelin, and cholecystokinin regulate appetite and satiety to maintain energy homeostasis. Leptin, an adipokine and a pleiotropic hormone, play major role in regulating the food intake, energy gain and energy expenditure. Using in silico approach, we have identified the major genes (LEP, LEPR, JAK2, STAT3, NPY, POMC, IRS1, SOCS3) that play crucial role in leptin signaling pathway. Further, eight miRNAs (hsa‐miR‐204‐5p, hsa‐miR‐211‐5p, hsa‐miR‐30, hsa‐miR‐3163, hsa‐miR‐33a‐3p, hsa‐miR‐548, hsa‐miR‐561‐3p, hsa‐miR‐7856‐5p) from TargetScan 8.0 database were screened out that commonly target these genes. The role of these miRNAs should be explored as they might play vital role in regulating the appetite, energy metabolism, metabolic diseases (obesity, type 2 diabetes, cardiovascular diseases, inflammation), and to combat extreme environments. The miRNAs regulating leptin signaling and appetite may be useful for developing novel therapeutics for metabolic diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Defence Institute of Physiology and Allied Sciences, Delhi, India.
ORCID profiles: Geetha Suryakumar
Cite
APA
Mondal, S., Rathor, R., Singh, S. N., & Suryakumar, G. (2024). miRNA and leptin signaling in metabolic diseases and at extreme environments. Pharmacology Research & Perspectives, 12(4). https://doi.org/10.1002/prp2.1248
Vancouver
Mondal S, Rathor R, Singh SN, Suryakumar G. miRNA and leptin signaling in metabolic diseases and at extreme environments. Pharmacology Research & Perspectives. 2024;12(4). doi:10.1002/prp2.1248
BibTeX
@article{Mondal2024,
author = {Mondal, Samrita and Rathor, Richa and Singh, Som Nath and Suryakumar, Geetha},
title = {miRNA and leptin signaling in metabolic diseases and at extreme environments},
journal = {Pharmacology Research & Perspectives},
year = {2024},
volume = {12},
number = {4},
doi = {10.1002/prp2.1248}
}
EUVIMED